X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (338) 338
index medicus (327) 327
male (193) 193
female (174) 174
heterocyclic compounds, 3-ring - therapeutic use (154) 154
hiv infections - drug therapy (143) 143
adult (140) 140
heterocyclic compounds, 3-ring - adverse effects (140) 140
heterocyclic compounds, 3-ring - administration & dosage (129) 129
middle aged (126) 126
heterocyclic compounds, 3-ring - pharmacology (116) 116
pharmacology & pharmacy (96) 96
animals (84) 84
raltegravir (80) 80
double-blind (79) 79
infectious diseases (79) 79
treatment outcome (79) 79
dolutegravir (74) 74
aged (70) 70
simeprevir (64) 64
drug therapy, combination (63) 63
heterocyclic compounds, 3-ring - pharmacokinetics (63) 63
drug therapy (61) 61
hiv (56) 56
once-daily dolutegravir (56) 56
analysis (54) 54
hiv integrase inhibitors - therapeutic use (52) 52
immunology (52) 52
therapy (51) 51
hiv integrase inhibitors - adverse effects (50) 50
mice (49) 49
young adult (49) 49
antiviral agents - therapeutic use (48) 48
sulfonamides - therapeutic use (46) 46
pharmacokinetics (45) 45
hepatitis c, chronic - drug therapy (44) 44
antiretroviral-naive adults (43) 43
clinical trials (43) 43
hiv infections - virology (43) 43
abridged index medicus (42) 42
drug interactions (42) 42
hiv infection (42) 42
hiv integrase inhibitors - administration & dosage (40) 40
hiv-1 - drug effects (40) 40
antiviral agents (39) 39
human immunodeficiency virus--hiv (38) 38
adolescent (37) 37
anti-hiv agents - therapeutic use (37) 37
infection (37) 37
oncology (37) 37
research (37) 37
health aspects (36) 36
hepacivirus - genetics (36) 36
safety (36) 36
care and treatment (35) 35
anti-hiv agents - adverse effects (34) 34
aids/hiv (33) 33
anti-hiv agents - administration & dosage (33) 33
antiretroviral therapy (33) 33
drug resistance, viral (33) 33
article (32) 32
drug administration schedule (32) 32
sulfonamides - adverse effects (32) 32
viral load (32) 32
antiretroviral drugs (31) 31
gastroenterology & hepatology (31) 31
hepatitis c virus (31) 31
hiv integrase inhibitors - pharmacokinetics (31) 31
sofosbuvir (31) 31
dose-response relationship, drug (30) 30
drug combinations (30) 30
genotype (30) 30
ribavirin - therapeutic use (30) 30
hepatitis c (29) 29
rna, viral - blood (29) 29
uridine monophosphate - analogs & derivatives (29) 29
hiv-1 infection (28) 28
microbiology (28) 28
hepacivirus - drug effects (27) 27
proto-oncogene proteins c-akt - antagonists & inhibitors (27) 27
resistance (27) 27
virology (27) 27
cancer (26) 26
clinical trials as topic (26) 26
double-blind method (26) 26
hiv integrase inhibitors - pharmacology (26) 26
hiv-1 (26) 26
dosage and administration (25) 25
heterocyclic compounds, 3-ring - chemistry (25) 25
integrase inhibitor (25) 25
interferon-alpha - therapeutic use (25) 25
medicine, general & internal (25) 25
toxicology (25) 25
efficacy (24) 24
mutation (24) 24
patients (24) 24
heterocyclic compounds, 3-ring (23) 23
initial treatment (23) 23
integrase (23) 23
internal medicine (23) 23
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (389) 389
German (3) 3
Spanish (2) 2
French (1) 1
Hungarian (1) 1
Japanese (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
AIDS, ISSN 0269-9370, 08/2017, Volume 31, Issue 13, pp. 1853 - 1858
Journal Article
Hepatology, ISSN 0270-9139, 12/2013, Volume 58, Issue 6, pp. 1918 - 1929
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2013, Volume 207, Issue 5, pp. 740 - 748
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9936, pp. 2222 - 2231
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 19, pp. 1807 - 1818
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9893, pp. 700 - 708
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 403 - 413
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 7, pp. 1669 - 1679.e3
Background & Aims Simeprevir is an oral, once-daily inhibitor of hepatitis c virus (HCV) protease NS3/4A. We investigated the safety and efficacy of simeprevir... 
Gastroenterology and Hepatology | Drug | Chronic Hepatitis C | DAA | PROMISE | ALPHA-2A | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | MANAGEMENT | CHRONIC HEPATITIS-C | PEGYLATED INTERFERON | BOCEPREVIR | RETREATMENT | GASTROENTEROLOGY & HEPATOLOGY | ONCE-DAILY TMC435 | Recombinant Proteins - therapeutic use | Recurrence | Simeprevir | Hepatitis C - drug therapy | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins - adverse effects | North America | Polyethylene Glycols - therapeutic use | Viral Load | Young Adult | Time Factors | Hepatitis C - blood | Protease Inhibitors - adverse effects | Adult | Female | Drug Therapy, Combination | Protease Inhibitors - therapeutic use | Hepacivirus - drug effects | Double-Blind Method | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Treatment Outcome | Biomarkers - blood | Hepatitis C - diagnosis | Hepacivirus - enzymology | Sulfonamides - therapeutic use | Asia | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Heterocyclic Compounds, 3-Ring - adverse effects | Heterocyclic Compounds, 3-Ring - therapeutic use | Sulfonamides - adverse effects | Hepacivirus - growth & development | Viral Nonstructural Proteins - metabolism | Aged | Interferon-alpha - adverse effects | Viral Nonstructural Proteins - antagonists & inhibitors | Medical colleges | Care and treatment | Proteases | Interferon alpha | Clinical trials | Product development | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Life Sciences
Journal Article